Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 42Unknown 32Recruiting 24Active not recruiting 10Terminated 9Not yet recruiting 9Withdrawn 4Enrolling by invitation 4No longer available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Liver Cirrhosis × Clear all
NCT05817994 2024-11-19

REGAL

Sheikh Shakhbout Medical City

Withdrawn
Gastrointestinal

Hepatitis, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure, Acute

NCT02899325 2023-02-21

FDGal PET/CT to Detect Hepatocellular Carcinoma

British Columbia Cancer Agency

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT02289300 2020-01-13

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

A2 Healthcare Taiwan Corporation

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT01501240 2014-01-28

PriMPa

Asan Medical Center

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡